Stifel Nicolaus Keeps Their Buy Rating on Neurogene (NGNE)
Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene (NGNE – Research Report) today and set a price target of $46.00. The ...
Stifel Nicolaus Reaffirms Their Buy Rating on MBX Biosciences, Inc. (MBX)
Stifel Nicolaus analyst Annabel Samimy maintained a Buy rating on MBX Biosciences, Inc. (MBX – Research Report) today. The company’s shares ...
Bureau of Meteorology22h
Harvey Forecast
Partly cloudy. Slight chance of a shower. Winds west to northwesterly 25 to 35 km/h becoming light in the late evening. Sun protection recommended from 8:30 am to 4:30 pm, UV Index predicted to reach ...